Skip to main content
Top
Published in: Supportive Care in Cancer 9/2007

01-09-2007 | Editorial

Cancer symptom clusters—a dynamic construct

Authors: Jordanka Kirkova, Declan Walsh

Published in: Supportive Care in Cancer | Issue 9/2007

Login to get access

Excerpt

Cancer symptoms are influenced by disease progression, treatment, time, patient personality, and demographic factors: age, gender, performance status [1, 2]. Symptom experience may be genetically predetermined [3]. Understanding cancer symptoms as dynamic constructs helps us understand the multifaceted character of the disease process and hopefully improve patient care by improving symptom assessment and management. Cancer patients have multiple symptoms, which often appear in groups or clusters [2, 4]. Symptom research has identified a separate symptom entity, i.e., “a symptom cluster” [46]. Symptom clusters consist of co-occurrence of two or more symptoms or symptom correlation based upon a particular symptom domain (prevalence, severity, distress) [5, 7]. The relationship among the symptoms within the cluster is assumed to be stronger than that across different clusters [5, 7]. Symptom clusters may influence disease course, treatment, function, quality of life (QoL), or prognosis, which differs from the sum of individual symptoms [7]. Methodological issues in cluster research include lack of consensus on cluster definition, instruments, study design, and statistical analyses used to identify clusters [79]. Further studies in cancer like the one by Chow and colleagues (in this issue) contribute to cluster research and our knowledge of its clinical meaning [4, 5, 1012]. …
Literature
1.
go back to reference Given CW, Given BA, Stommel M (1994) The impact of age, treatment, and symptoms on the physical and mental health of cancer patients. A longitudinal perspective. Cancer 74(7 Suppl):2128–2138PubMedCrossRef Given CW, Given BA, Stommel M (1994) The impact of age, treatment, and symptoms on the physical and mental health of cancer patients. A longitudinal perspective. Cancer 74(7 Suppl):2128–2138PubMedCrossRef
2.
go back to reference Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179PubMedCrossRef Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179PubMedCrossRef
4.
go back to reference Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836PubMedCrossRef Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836PubMedCrossRef
5.
go back to reference Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed
6.
go back to reference Miaskowski C, Dodd M, Lee K (2004) Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 32(32):17–21PubMedCrossRef Miaskowski C, Dodd M, Lee K (2004) Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 32(32):17–21PubMedCrossRef
7.
go back to reference Kim HJ, McGuire DB, Tulman L et al (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282 (quiz 283–284)PubMedCrossRef Kim HJ, McGuire DB, Tulman L et al (2005) Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs 28(4):270–282 (quiz 283–284)PubMedCrossRef
8.
go back to reference Miaskowski C (2006) Symptom clusters: establishing the link between clinical practice and symptom management research. Support Care Cancer 14(8):792–794PubMedCrossRef Miaskowski C (2006) Symptom clusters: establishing the link between clinical practice and symptom management research. Support Care Cancer 14(8):792–794PubMedCrossRef
9.
go back to reference Barsevick AM, Whitmer K, Nail LM et al (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 31(1):85–95PubMedCrossRef Barsevick AM, Whitmer K, Nail LM et al (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 31(1):85–95PubMedCrossRef
10.
go back to reference Bender CM, Ergyn FS, Rosenzweig MQ et al (2005) Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28(3):219–225PubMedCrossRef Bender CM, Ergyn FS, Rosenzweig MQ et al (2005) Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28(3):219–225PubMedCrossRef
11.
go back to reference Wang XS, Fairclough DL, Liao Z et al (2006) Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24(27):4485–4491PubMedCrossRef Wang XS, Fairclough DL, Liao Z et al (2006) Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24(27):4485–4491PubMedCrossRef
12.
13.
go back to reference Armstrong TS, Cohen MZ, Eriksen LR et al (2004) Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh 36(3):197–206PubMedCrossRef Armstrong TS, Cohen MZ, Eriksen LR et al (2004) Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh 36(3):197–206PubMedCrossRef
14.
go back to reference Miaskowski C, Lee KA (1999) Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 17(5):320–332PubMedCrossRef Miaskowski C, Lee KA (1999) Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 17(5):320–332PubMedCrossRef
15.
go back to reference Francoeur RB (2005) The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage 29(2):130–155PubMedCrossRef Francoeur RB (2005) The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage 29(2):130–155PubMedCrossRef
16.
go back to reference Gift AG, Jablonski A, Stommel M et al (2004) Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum 31(2):202–212PubMedCrossRef Gift AG, Jablonski A, Stommel M et al (2004) Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum 31(2):202–212PubMedCrossRef
17.
go back to reference Okuyama T, Wang XS, Akechi T et al (2003) Japanese version of the MD Anderson symptom inventory: a validation study. J Pain Symptom Manage 26(6):1093–1104PubMedCrossRef Okuyama T, Wang XS, Akechi T et al (2003) Japanese version of the MD Anderson symptom inventory: a validation study. J Pain Symptom Manage 26(6):1093–1104PubMedCrossRef
18.
go back to reference Lee BN, Dantzer R, Langley KE et al (2004) A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11(5):279–292PubMedCrossRef Lee BN, Dantzer R, Langley KE et al (2004) A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11(5):279–292PubMedCrossRef
19.
go back to reference Gift AG, Stommel M, Jablonski A et al (2003) A cluster of symptoms over time in patients with lung cancer. Nurs Res 52(6):393–400PubMedCrossRef Gift AG, Stommel M, Jablonski A et al (2003) A cluster of symptoms over time in patients with lung cancer. Nurs Res 52(6):393–400PubMedCrossRef
20.
go back to reference Barsevick AM, Dudley WN, Beck SL (2006) Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 55(5):366–372PubMedCrossRef Barsevick AM, Dudley WN, Beck SL (2006) Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 55(5):366–372PubMedCrossRef
21.
go back to reference Beck SL, Dudley WN, Barsevick A (2005) Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum 32(3):542PubMedCrossRef Beck SL, Dudley WN, Barsevick A (2005) Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum 32(3):542PubMedCrossRef
22.
23.
go back to reference Clark WC, Yang JC, Tsui SL et al (2002) Unidimensional pain rating scales: a multidimensional affect and pain survey (MAPS) analysis of what they really measure. Pain 98(3):241–247PubMedCrossRef Clark WC, Yang JC, Tsui SL et al (2002) Unidimensional pain rating scales: a multidimensional affect and pain survey (MAPS) analysis of what they really measure. Pain 98(3):241–247PubMedCrossRef
24.
go back to reference Knotkova H, Crawford Clark W, Mokrejs P et al (2004) What do ratings on unidimensional pain and emotion scales really mean? A multidimensional affect and pain survey (MAPS) analysis of cancer patient responses. J Pain Symptom Manage 28(1):19–27PubMedCrossRef Knotkova H, Crawford Clark W, Mokrejs P et al (2004) What do ratings on unidimensional pain and emotion scales really mean? A multidimensional affect and pain survey (MAPS) analysis of cancer patient responses. J Pain Symptom Manage 28(1):19–27PubMedCrossRef
Metadata
Title
Cancer symptom clusters—a dynamic construct
Authors
Jordanka Kirkova
Declan Walsh
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0259-2

Other articles of this Issue 9/2007

Supportive Care in Cancer 9/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine